Sialidase treatment exposes the beta1-integrin active ligand binding site on HL60 cells and increases binding to fibronectin - PubMed (original) (raw)
Sialidase treatment exposes the beta1-integrin active ligand binding site on HL60 cells and increases binding to fibronectin
R K Pretzlaff et al. Cell Adhes Commun. 2000.
Abstract
The migration of neutrophils from the circulation to areas of inflammation is the result of the sequential activation of multiple cellular adhesion molecules. beta1-Integrins are cell surface glycoproteins and the class of adhesion molecules responsible for binding to the extracellular matrix. The goal of this study was to determine the contribution of glycosylation, specifically the presence of sialic acid, to beta1-integrin adhesion in a neutrophil model. beta1-Integrins on differentiated HL60 cells were remodeled by treatment with the exoglycosidases, sialidase and beta-galactosidase. beta1-Integrin activity was determined by measuring adherence to the extracellular matrix protein fibronectin. The expression of beta1-integrins, beta2-integrins and activated beta1-integrins was determined by flow cytometry. Remodeling of beta1-integrins by treatment with sialidase increased adhesion by greater than 1,000%. Flow cytometric analysis of remodeled beta1-integrins demonstrated an increased expression of the activated beta1-integrin, but only minor increases in the expression of total beta1- and beta2-integrins. We postulate that glycosidase treatment increases adhesion and expression of activated beta1-integrins by exposure of the normally hidden ligand-binding site. The glycosylation of beta1-integrins on neutrophils may act to hide the ligand-binding site in unstimulated cells thereby contributing to the affinity modulation observed in neutrophil beta1-integrin function.
Similar articles
- Beta1 integrins are distributed in adhesion structures with fibronectin and caveolin and in coated pits.
Boyd ND, Chan BM, Petersen NO. Boyd ND, et al. Biochem Cell Biol. 2003 Oct;81(5):335-48. doi: 10.1139/o03-063. Biochem Cell Biol. 2003. PMID: 14569297 - Beta1 integrin activation on human neutrophils promotes beta2 integrin-mediated adhesion to fibronectin.
van den Berg JM, Mul FP, Schippers E, Weening JJ, Roos D, Kuijpers TW. van den Berg JM, et al. Eur J Immunol. 2001 Jan;31(1):276-84. doi: 10.1002/1521-4141(200101)31:1<276::AID-IMMU276>3.0.CO;2-D. Eur J Immunol. 2001. PMID: 11265644 - Intracellular calcium requirements for beta1 integrin activation.
Rowin ME, Whatley RE, Yednock T, Bohnsack JF. Rowin ME, et al. J Cell Physiol. 1998 May;175(2):193-202. doi: 10.1002/(SICI)1097-4652(199805)175:2<193::AID-JCP9>3.0.CO;2-J. J Cell Physiol. 1998. PMID: 9525478 - Integrins in cell adhesion and signaling.
Akiyama SK. Akiyama SK. Hum Cell. 1996 Sep;9(3):181-6. Hum Cell. 1996. PMID: 9183647 Review. - The characteristics and the multiple functions of integrin β1 in human cancers.
Sun L, Guo S, Xie Y, Yao Y. Sun L, et al. J Transl Med. 2023 Nov 6;21(1):787. doi: 10.1186/s12967-023-04696-1. J Transl Med. 2023. PMID: 37932738 Free PMC article. Review.
Cited by
- Exploration into Galectin-3 Driven Endocytosis and Lattices.
Shafaq-Zadah M, Dransart E, Mani SK, Sampaio JL, Bouidghaghen L, Nilsson UJ, Leffler H, Johannes L. Shafaq-Zadah M, et al. Biomolecules. 2024 Sep 18;14(9):1169. doi: 10.3390/biom14091169. Biomolecules. 2024. PMID: 39334935 Free PMC article. - Serum Sialyl Fibronectin Is an Indicator of Good Prognosis in Thyroid Cancer.
Takeyama H, Manome Y. Takeyama H, et al. Cancer Diagn Progn. 2023 Jan 3;3(1):75-84. doi: 10.21873/cdp.10182. eCollection 2023 Jan-Feb. Cancer Diagn Progn. 2023. PMID: 36632594 Free PMC article. - ST6Gal1: Oncogenic signaling pathways and targets.
Gc S, Bellis SL, Hjelmeland AB. Gc S, et al. Front Mol Biosci. 2022 Aug 29;9:962908. doi: 10.3389/fmolb.2022.962908. eCollection 2022. Front Mol Biosci. 2022. PMID: 36106023 Free PMC article. Review. - Altered sialidase expression in human myeloid cells undergoing apoptosis and differentiation.
Hyun SW, Feng C, Liu A, Lillehoj EP, Trotta R, Kingsbury TJ, Passaniti A, Lugkey KN, Chauhan S, Cipollo JF, Luzina IG, Atamas SP, Cross AS, Goldblum SE. Hyun SW, et al. Sci Rep. 2022 Aug 19;12(1):14173. doi: 10.1038/s41598-022-18448-6. Sci Rep. 2022. PMID: 35986080 Free PMC article. - Re-Expression of Poly/Oligo-Sialylated Adhesion Molecules on the Surface of Tumor Cells Disrupts Their Interaction with Immune-Effector Cells and Contributes to Pathophysiological Immune Escape.
Jarahian M, Marofi F, Maashi MS, Ghaebi M, Khezri A, Berger MR. Jarahian M, et al. Cancers (Basel). 2021 Oct 16;13(20):5203. doi: 10.3390/cancers13205203. Cancers (Basel). 2021. PMID: 34680351 Free PMC article. Review.